Sort by
Refine Your Search
-
Innovation Reference code: 50141616_2 ? 2025/KS 3 Commencement date: as soon as possible Work location: Geesthacht Application deadline: June 18th, 2025 The applicant will work in the frame of the EU Research
-
, use of coastal environments, and other human drivers. Scientist in Marine Ecosystems and Digital Innovation Reference code: 50141616_2 – 2025/KS 3 Commencement date: as soon as possible Work location
-
(SDPs). You will design climate change mitigation scenarios that respect both climate targets and sustainable development goals using the REMIND model, one of the world’s leading integrated energy-economy
-
of the following topics: physical layer design for ultra energy-efficient wireless spike-based sensor node communication digital baseband design for energy-efficient terabit/sec wireless communications using
-
Senior Scientist / Group Leader on Bioinformatics / Computational Biology on RNA Regulation in Disea
to pushing the boundaries of biomedical innovation. Your role As a senior scientist and group leader, you will: Lead high-impact projects in RNA biology, including bulk and single-cell RNA-seq
-
, including but not limited to cancer, metabolic disorders, and infections. The research design involves the integration of large-scale biological datasets derived from both the host and the microbiome
-
patients for personalized therapies Contribute to the design of validation strategies and collaborate on confirming targets through molecular and immunological assays Present and discuss in internal meetings
-
this professorship, the Rostock University Medical Center aims to support the implementation of engineering and neuroscientific innovation in healthcare. At the same time, the professorship strengthens the focus
-
function and cellular organization, structural bioinformatics, protein design, synthetic biology, chemical biology approaches to manipulate and engineer biological systems, high-throughput biochemistry, in
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe